Early skin cancer detection, for everyone

Skin cancer is the most common cancer worldwide, with over 5 million new cases annually in the U.S.—yet 50% of care needs will go unmet by 2030 due to a critical shortage of dermatologists.

SkinBit is redefining early skin cancer detection with the world’s first AI-powered millimeter-wave imaging platform, creating a living digital twin of your skin health. This revolutionary technology delivers 20% higher accuracy than current methods, providing fast, noninvasive, full-body skin scans in under 60 seconds.

By eliminating long wait times, reducing unnecessary biopsies, and making professional-grade screening widely accessible, SkinBit not only saves lives but also spares patients from the devastating impact of late-stage treatment.

With clinically validated technology, a clear go-to-market strategy, and a projected $70M in revenue within five years, we are building the future of dermatologic care—where early detection is the rule, not the exception.

From Patient to Founder

Jonathan's Melanoma Journey Births SkinBit

During a 2020 dermatologist visit, Jonathan's doctor found melanoma on his nose beneath his mask. Initially facing extensive nose reconstruction at Stanford, he advocated for Mohs surgery, which removed just 10-15% of what was planned. After being declared cancer-free, Jonathan founded SkinBit, a startup delivering faster, more precise, and affordable skin cancer monitoring and treatment solutions.

Seed Round …

The Team

Jonathan Benassaya · Founder, CEO

Melanoma survivor, Jonathan has founded and exited four consumer companies, including Deezer (listed on Euronext), Life360, and Meta. His expertise in building scalable businesses and his passion for innovative solutions drive SkinBit's mission to revolutionize skin cancer detection.
Dr. Justin Ko, MD · Co-Founder, Medical Advisor

As the Chief of Medical Dermatology at Stanford Medicine, Dr. Ko brings unparalleled expertise in skin cancer diagnostics and digital health innovation. His leadership in AI-driven dermatology and patient-centered care ensures that SkinBit's solutions are clinically sound and impactful.
Bill Dower, PhD · Co-Founder, CTO

An expert in radar technology with a PhD in synthetic aperture radar, Bill has led radar programs for defense at Raytheon and startups at Epirus and Chaos. His technical insights are crucial in developing SkinBit's non-invasive imaging solutions.
Manuel Colom, Co-Founder, CXO

With 20 years of experience in UI/UX design and a history of working with companies like Apple, as the Co-founder of 3 startups. Manuel focuses on crafting intuitive, user-friendly interfaces that enhance the patient journey while shaping the brand identity of SkinBit’s products.
Radek Grzeszczuk, Co-Founder, Computer Vision Lead

With over 20 years of experience in computer vision, Radek has pioneered groundbreaking work in deep learning and 3D imaging systems. His expertise in building scalable, real-time imaging platforms is central to SkinBit's revolutionary imaging technology.